期刊文献+

采用光学相干断层成像技术评价国产雷帕霉素洗脱支架术内膜覆盖情况 被引量:1

Evaluation on neointimal coverage of domestic sirolimus eluting stent after implantation for nine months by Optical Coherence Tomography (OCT)
暂未订购
导出
摘要 Objective:Confirming complete neointimal coverage after implantation of drug-eluting stent(DES)is clinically important because incomplete stent coverage is maybe responsible for late thrombosis and sudden cardiac death.Optical coherence tomography(OCT)is a high-resolution(≈10 μm)imaging technique capable of detecting a thin layer of neointimal hyperplasia(NIH)inside DES.Helios stent system(KinheIy Bio-tech Co(Shenzhen).Ltd)is a new generation of sirolimus eluting stents.Methods:Motorized optical coherence tomographic pullback was performed at 9-month follow-up to examine consecutive Helios stent mplantations in 10 patients.NIH thickness inside each strut and NIH area percentage inside each cross-section were measured.Results:In total,2063 struts in 296 mm stented segments were analyzed.Overall,NIH thickness were(95.7±66.62)μm,rates of exposed struts was 60.2% and the average NIH area percentage was 5.0618% ± 5.6625%.Conclusion:Our study suggests that dual antiplatelet therapy after Helios stent implantation must be continued at least 9months after DES implantation. Objective:Confirming complete neointimal coverage after implantation of drug-eluting stent(DES)is clinically important because incomplete stent coverage is maybe responsible for late thrombosis and sudden cardiac death.Optical coherence tomography(OCT)is a high-resolution(≈10 μm)imaging technique capable of detecting a thin layer of neointimal hyperplasia(NIH)inside DES.Helios stent system(KinheIy Bio-tech Co(Shenzhen).Ltd)is a new generation of sirolimus eluting stents.Methods:Motorized optical coherence tomographic pullback was performed at 9-month follow-up to examine consecutive Helios stent mplantations in 10 patients.NIH thickness inside each strut and NIH area percentage inside each cross-section were measured.Results:In total,2063 struts in 296 mm stented segments were analyzed.Overall,NIH thickness were(95.7±66.62)μm,rates of exposed struts was 60.2% and the average NIH area percentage was 5.0618% ± 5.6625%.Conclusion:Our study suggests that dual antiplatelet therapy after Helios stent implantation must be continued at least 9months after DES implantation.
出处 《心肺血管病杂志》 CAS 2010年第S1期79-80,共2页 Journal of Cardiovascular and Pulmonary Diseases
基金 北京市科委高科技战略主题计划资助项目(D0906006040191) 北京市科技新星计划资助项目(2007A001)
  • 相关文献

同被引文献20

  • 1Rber L,Kelbk H,Ostoijc M,et al.Effect of biolimus-elutingstents with biodegradable polymer vs bare-metal stents on cardio-vascular events among patients with acute myocardial infarction:the COMFORTABLE AMI randomized trial.JAMA,2012,308:777-787.
  • 2Wallace EL,Abdel-Latif A,Charnigo R,et al.Meta-analysis oflong-term outcomes for drug-eluting stents versus bare-metalstents in primary percutaneous coronary interventions for ST-Seg-ment elevation myocardial infarction.Am J Cardiol,2012,109:932-940.
  • 3Neumann FJ,Widimsky P,Belardi JA.One-year outcomes ofpatients with the zotarolimus-eluting coronary stent:RESOLUTEinternational Registry.EuroIntervention.2012,7:1181-1188.
  • 4Stenestrand U,James SK,Lindbck J,et al.Safety and efficacyof drug-eluting vs.bare metal stents in patients with diabetesmellitus:long-term follow-up in the Swedish coronary angiogra-phy and angioplasty registry(SCAAR).Eur Heart J,2010,31:177-186.
  • 5Vink MA,Dirksen MT,Suttorp MJ,et al.5-year follow-up afterprimary percutaneous coronary intervention with a paclitaxel-elu-ting stent versus a bare-metal stent in acute ST-segment elevationmyocardial infarction:a follow-up study of the PASSION(Pacli-taxel-Eluting Versus Conventional Stent in Myocardial Infarctionwith ST-Segment Elevation)trial.JACC Cardiovasc Interv,2011,4:24-29.
  • 6Jeger R,Pfisterer M,Alber H,et al.Newest-generation drug-e-luting and bare-metal stents combined with prasugrel-based anti-platelet therapy in large coronary arteries:the Basel stent kosteneffektivitts trial prospective validation examination partⅡ(BASKET-PROVEⅡ)trial design.Am Heart J,2012,163:136-141.
  • 7Spaulding C,Teiger E,Commeau P,et al.Four-year follow-upof TYPHOON(trial to assess the use of the CYPHer sirolimus-e-luting coronary stent in acute myocardial infarction treated withBallOON angioplasty).JACC Cardiovasc Interv,2011,4:14-23.
  • 8Van den Branden BJ,Rahel BM,Laarman GJ,et al.Five-yearclinical outcome after primary stenting of totally occluded nativecoronary arteries:a randomised comparison of bare metal stentimplantation with sirolimus-eluting stent implantation for the treat-ment of total coronary occlusions(PRISON II study).EuroInter-vention,2012,7:1189-1196.
  • 9Ma Q,Nie X,Yu M,et al.Rapamycin regulates the expressionand activity of krüppel-like transcription factor 2 in human um-bilical vein endothelial cells.PLoS One,2012,7:e43315.
  • 10Sabate M,Cequier A,Iiguez A,et al.Everolimus-eluting stentversus bare-metal stent in ST-segment elevation myocardial infarc-tion(EXAMINATION):1 year results of a randomised controlledtrial.Lancet,2012 Aug 31.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部